Severe steroid refractory gastritis induced by Nivolumab: A case report

BACKGROUND: Immune checkpoint inhibitors are widely used for treatment of many advanced malignancies. Lower gastrointestinal (GI) side effects, such as diarrhea and colitis, are common, but upper GI side effects are rarely reported. Consequently, the correct treatment of upper GI adverse events has...

Descripción completa

Detalles Bibliográficos
Autores principales: Vindum, Helene Hjorth, Agnholt, Jørgen S, Nielsen, Anders Winther Moelby, Nielsen, Mette Bak, Schmidt, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201147/
https://www.ncbi.nlm.nih.gov/pubmed/32390707
http://dx.doi.org/10.3748/wjg.v26.i16.1971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201147/
https://www.ncbi.nlm.nih.gov/pubmed/32390707
http://dx.doi.org/10.3748/wjg.v26.i16.1971

Ejemplares similares